Remove Finance Remove Innovation Remove Pharmaceuticals Remove Team
article thumbnail

Introducing 100 Coaches: Pay It Forward Champions

Marshall Goldsmith

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. Rod MacKenzie – Executive Vice President, Chief Development Officer for Pfizer, member of Pfizer’s Executive Leadership Team. Darek Lenart – Senior VP HR, Finance MasterCard. ’ Game.

article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. Yet they have already generated tens of millions of dollars in value for Roivant.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. How could digital printing improve your innovation, product development, and speed to market?

article thumbnail

Business Needs to Do What Government Can't

Harvard Business Review

Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. The future, he argued, lies with institutional forms based on networks, "an open, fluid team of teams". Breakthrough Finance. Breakthrough Science.

EPS 8
article thumbnail

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

Harvard Business Review

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8
article thumbnail

The Internet of Things Will Change Your Company, Not Just Your Products

Harvard Business Review

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. My favorite example of this is iRobot , the maker of the innovative Roomba vacuum.

article thumbnail

What a Changing NAFTA Could Mean for Doing Business in Mexico

Harvard Business Review

Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards.